WeRide Inc. Grants Restricted Share Units Under 2026 Share Plan

WeRide Inc. announced on September 23, 2026, the grant of 17,880,200 Restricted Share Units (RSUs) to 160 grantees, including its founder Dr. Han and co-founder Dr. Li, as well as 158 other employees. The RSUs were granted under the 2026 Share Plan, with no purchase price. The closing price of Class A Ordinary Shares on the grant date was HK$15.63. Vesting periods vary: RSUs for Dr. Han, Dr. Li, and senior management are subject to performance-based conditions linked to revenue, with a total vesting period of 36 months. RSUs for other grantees have a mixed vesting schedule of 23 to 45 months. The purpose of the grant is to incentivize and retain key personnel, aligning their interests with the company's long-term growth and shareholder value. The grants were approved by the Board, with relevant parties abstaining from voting. The company has sufficient shares available for future grants.